Attached files
| file | filename |
|---|---|
| 10-Q - FORM 10-Q - NOVELION THERAPEUTICS INC. | c20273e10vq.htm |
| EXCEL - IDEA: XBRL DOCUMENT - NOVELION THERAPEUTICS INC. | Financial_Report.xls |
| EX-31.1 - EXHIBIT 31.1 - NOVELION THERAPEUTICS INC. | c20273exv31w1.htm |
| EX-32.1 - EXHIBIT 32.1 - NOVELION THERAPEUTICS INC. | c20273exv32w1.htm |
| EX-31.2 - EXHIBIT 31.2 - NOVELION THERAPEUTICS INC. | c20273exv31w2.htm |
EXHIBIT 32.2
CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of QLT Inc. (the “Company”) for the quarterly
period ended June 30, 2011, as filed with the Securities and Exchange Commission on the
date hereof (the “Report”), I, Cameron R. Nelson, Vice President, Finance and Chief Financial
Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the
Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
| (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and |
| (2) | The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company at and for
the periods indicated. |
Dated: July 28, 2011
| /s/ Cameron R. Nelson | ||||
| Cameron R. Nelson | ||||
| Vice President, Finance and Chief Financial Officer (Principal Financial and Accounting Officer) |
||||